![Hong Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hong Wu
Corporate Officer/Principal bei
Peking University School of Pharmaceutical Sciences
Profil
Dr. Hong Wu is an Associate Member at European Molecular Biology Organization and a Dean & Professor at Peking University School of Pharmaceutical Sciences.
Dr. Wu was previously employed as an Independent Non-Executive Director by New Horizon Health Ltd., a Professor by David Geffen School of Medicine, and an Associate Director-Research by Jonsson Comprehensive Cancer Center.
He also served on the board at The Institute for Molecular Medicine.
He received his undergraduate degree from Peking Union Medical College and a doctorate degree from Harvard Medical School.
Aktive Positionen von Hong Wu
| Unternehmen | Position | Beginn |
|---|---|---|
Peking University School of Pharmaceutical Sciences
 Peking University School of Pharmaceutical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2013 |
European Molecular Biology Organization | Corporate Officer/Principal | 01.01.2016 |
Ehemalige bekannte Positionen von Hong Wu
| Unternehmen | Position | Ende |
|---|---|---|
| NEW HORIZON HEALTH LIMITED | Direktor/Vorstandsmitglied | 01.10.2024 |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2013 |
The Institute for Molecular Medicine | Direktor/Vorstandsmitglied | - |
Jonsson Comprehensive Cancer Center
 Jonsson Comprehensive Cancer Center Medical/Nursing ServicesHealth Services Part of University of California, Jonsson Comprehensive Cancer Center is a multidisciplinary cancer center that integrates basic, translational, and clinical research to advance personalized cancer care across all stages of treatment. The company is based in Los Angeles, CA. The center offers comprehensive services including prevention, early detection, precision diagnostics, innovative therapies, survivorship support, and access to clinical trials. It specializes in a wide range of cancers such as breast, prostate, lung, colorectal, kidney, and sarcoma, and provides targeted treatments and immunotherapies. Research is organized into interdisciplinary programs focusing on cancer stem cell biology, immunotherapy, molecular imaging, and gene regulation. The center manages clinical trial infrastructure, supports education and training for trainees and faculty, and conducts cancer prevention and control research with community outreach. Philanthropy supports research, clinical trials, and patient services, including integrative oncology programs. The center provides language and disability access services and fosters a patient-centered environment. | Corporate Officer/Principal | - |
Ausbildung von Hong Wu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
49
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
European Molecular Biology Organization | |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking Union Medical College
 Peking Union Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center Medical/Nursing ServicesHealth Services Part of University of California, Jonsson Comprehensive Cancer Center is a multidisciplinary cancer center that integrates basic, translational, and clinical research to advance personalized cancer care across all stages of treatment. The company is based in Los Angeles, CA. The center offers comprehensive services including prevention, early detection, precision diagnostics, innovative therapies, survivorship support, and access to clinical trials. It specializes in a wide range of cancers such as breast, prostate, lung, colorectal, kidney, and sarcoma, and provides targeted treatments and immunotherapies. Research is organized into interdisciplinary programs focusing on cancer stem cell biology, immunotherapy, molecular imaging, and gene regulation. The center manages clinical trial infrastructure, supports education and training for trainees and faculty, and conducts cancer prevention and control research with community outreach. Philanthropy supports research, clinical trials, and patient services, including integrative oncology programs. The center provides language and disability access services and fosters a patient-centered environment. | Health Services |
The Institute for Molecular Medicine | |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University School of Pharmaceutical Sciences
Peking University School of Pharmaceutical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Horizon Health Ltd.
 New Horizon Health Ltd. Medical/Nursing ServicesHealth Services Provides cancer screening and medical laboratory services | Health Services |
